{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T03:25:52Z","timestamp":1782357952074,"version":"3.54.5"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T00:00:00Z","timestamp":1646611200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T00:00:00Z","timestamp":1646611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100011253","name":"State Key Laboratory of Protein and Plant Gene Research","doi-asserted-by":"publisher","award":["G2018004"],"award-info":[{"award-number":["G2018004"]}],"id":[{"id":"10.13039\/501100011253","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Congenital adrenal hyperplasia (CAH), characterized by defective adrenal steroidogenesis, is transmitted in an autosomal recessive manner. Mutations in the steroid 21-hydroxylase gene<jats:italic>CYP21A2<\/jats:italic>causing steroid 21-hydroxylase deficiency account for most cases of CAH. The c.145l-1452delGGinsC gene mutation is rare, and only one case has been reported, but the form of gene mutation is different from this case, resulting in different clinical phenotype. The most common pathogenic genotype of CAH is a homozygous or compound heterozygous mutation, but CAH patients homozygous for the p.I173N mutation and heterozygous for the c.1451-1452delGGinsC mutation have not been reported previously. We report herein a familial case of CAH, in which both siblings carry the rare homozygous p.I173N mutation and heterozygous c.1451-1452delGGinsC mutation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case presentation<\/jats:title><jats:p>The proband showed amenorrhea, infertility, polycystic ovaries, and increased levels of androgen, rather than the typical clinical manifestations of CAH such as an adrenal crisis or masculine vulva, so was misdiagnosed with polycystic ovary syndrome for many years. Following a correct diagnosis of CAH, she was given glucocorticoid treatment, her menstruation became more regular, and she became pregnant and delivered a healthy baby girl.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The genotypes may be p.I173N homozygous or p.I173N\/c.1451-1452delGGinsC heterozygous, both mutations could be pathogenic. This complex combination of mutations has not been reported or studied before. Through the report and analysis of this genotype, the content of CAH gene bank is enriched and the misdiagnosis rate of CAH is reduced.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12902-022-00969-w","type":"journal-article","created":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T10:06:57Z","timestamp":1646647617000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Congenital adrenal hyperplasia with homozygous and heterozygous mutations: a rare family case report"],"prefix":"10.1186","volume":"22","author":[{"given":"Tiantian","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwen","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangyao","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijuan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,7]]},"reference":[{"key":"969_CR1","doi-asserted-by":"publisher","first-page":"624507","DOI":"10.3389\/fendo.2021.624507","volume":"12","author":"Z Li","year":"2021","unstructured":"Li Z, Huang L, Du C, et al. Analysis of the screening results for congenital adrenal hyperplasia involving 7.85 Million newborns in China: a systematic review and meta-analysis. Front Endocrinol (Lausanne). 2021;12:624507.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"969_CR2","doi-asserted-by":"publisher","first-page":"723","DOI":"10.3389\/fendo.2019.00723","volume":"10","author":"A Chatziaggelou","year":"2019","unstructured":"Chatziaggelou A, Sakkas EG, Votino R, Papagianni M, Mastorakos G. Assisted Reproduction in Congenital Adrenal Hyperplasia. Front Endocrinol (Lausanne). 2019;10:723.","journal-title":"Front Endocrinol (Lausanne)."},{"key":"969_CR3","doi-asserted-by":"publisher","unstructured":"Narasimhan ML, Khattab A. Genetics of congenital adrenal hyperplasia and genotype-phenotype correlation. Fertil Steril.\u00a0United States;\u00a02019;111(1):24\u20139.\u00a0ISSN: 0015-0282. https:\/\/doi.org\/10.1016\/j.fertnstert.2018.11.007.","DOI":"10.1016\/j.fertnstert.2018.11.007"},{"issue":"1","key":"969_CR4","doi-asserted-by":"publisher","first-page":"25","DOI":"10.18388\/abp.2017_2343","volume":"65","author":"R Podg\u00f3rski","year":"2018","unstructured":"Podg\u00f3rski R, Aebisher D, Stompor M, Podg\u00f3rska D, Mazur A. Congenital adrenal hyperplasia: clinical symptoms and diagnostic methods. Acta Biochim Pol. 2018;65(1):25\u201333.","journal-title":"Acta Biochim Pol."},{"issue":"2","key":"969_CR5","doi-asserted-by":"publisher","first-page":"103","DOI":"10.2174\/1872214809666151005123928","volume":"9","author":"E Przybylik-Mazurek","year":"2015","unstructured":"Przybylik-Mazurek E, Kurzynska A, Skalniak A, Hubalewska-Dydejczyk A. Current approaches to the diagnosis of classical form of congenital adrenal hyperplasia. Recent Pat Endocr Metab Immune Drug Discov. 2015;9(2):103\u201310.","journal-title":"Recent Pat Endocr Metab Immune Drug Discov."},{"issue":"1","key":"969_CR6","doi-asserted-by":"crossref","first-page":"6","DOI":"10.15605\/jafes.033.01.02","volume":"33","author":"AZ Juniarto","year":"2018","unstructured":"Juniarto AZ, Ulfah M, Ariani MD, Utari A, Faradz SM. Phenotypic Variation of 46,XX Late Identified Congenital Adrenal Hyperplasia among Indonesians. J ASEAN Fed Endocr Soc. 2018;33(1):6\u201311.","journal-title":"J ASEAN Fed Endocr Soc."},{"key":"969_CR7","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.steroids.2016.01.007","volume":"108","author":"R Wang","year":"2016","unstructured":"Wang R, Yu Y, Ye J, et al. 21-hydroxylase deficiency-induced congenital adrenal hyperplasia in 230 Chinese patients: Genotype-phenotype correlation and identification of nine novel mutations. Steroids. 2016;108:47\u201355.","journal-title":"Steroids."},{"key":"969_CR8","unstructured":"\u9093\u5c0f\u8273, \u80e1\u8700\u7ea2, \u5f20\u6728\u52cb. \u5355\u7eaf\u7537\u6027\u5316\u578b\u5148\u5929\u6027\u80be\u4e0a\u817a\u76ae\u8d28\u589e\u751f\u75c7\u75c5\u4f8b\u62a5\u544a\u5e76\u6587\u732e\u590d\u4e60. \u5185\u79d1\u6025\u5371\u91cd\u75c7\u6742\u5fd7. 2014. 20(6): 382-385."},{"issue":"5","key":"969_CR9","first-page":"569","volume":"38","author":"AP Barannik","year":"2012","unstructured":"Barannik AP, Lavrova NV, Shilov IA, Koltunova AA, Ozolinia LA, Patrushev LI. Unique steroid 21-hydroxylase gene CYP21A2 polymorphism in patients with hyperandrogenism signs. Bioorg Khim. 2012;38(5):569\u201376.","journal-title":"Bioorg Khim."},{"issue":"1","key":"969_CR10","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/cen.14190","volume":"93","author":"CS Fern\u00e1ndez","year":"2020","unstructured":"Fern\u00e1ndez CS, Taboas M, Bruque CD, et al. Genetic characterization of a large cohort of Argentine 21-hydroxylase Deficiency. Clin Endocrinol (Oxf). 2020;93(1):19\u201327.","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"7","key":"969_CR11","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1073\/pnas.1221133110","volume":"110","author":"S Haider","year":"2013","unstructured":"Haider S, Islam B, D'Atri V, et al. Structure-phenotype correlations of human CYP21A2 mutations in congenital adrenal hyperplasia. Proc Natl Acad Sci U S A. 2013;110(7):2605\u201310.","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"7","key":"969_CR12","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.1073\/pnas.1300057110","volume":"110","author":"MI New","year":"2013","unstructured":"New MI, Abraham M, Gonzalez B, et al. Genotype-phenotype correlation in 1,507 families with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency. Proc Natl Acad Sci U S A. 2013;110(7):2611\u20136.","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"1","key":"969_CR13","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1210\/jc.2008-1174","volume":"94","author":"LG Gomes","year":"2009","unstructured":"Gomes LG, Huang N, Agrawal V, Mendon\u00e7a BB, Bachega TA, Miller WL. Extraadrenal 21-hydroxylation by CYP2C19 and CYP3A4: effect on 21-hydroxylase deficiency. J Clin Endocrinol Metab. 2009;94(1):89\u201395.","journal-title":"J Clin Endocrinol Metab."},{"issue":"15","key":"969_CR14","doi-asserted-by":"publisher","first-page":"7232","DOI":"10.1073\/pnas.89.15.7232","volume":"89","author":"A Wedell","year":"1992","unstructured":"Wedell A, Ritz\u00e9n EM, Haglund-Stengler B, Luthman H. Steroid 21-hydroxylase deficiency: three additional mutated alleles and establishment of phenotype-genotype relationships of common mutations. Proc Natl Acad Sci U S A. 1992;89(15):7232\u20136.","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"Pt A","key":"969_CR15","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jsbmb.2016.03.035","volume":"165","author":"KK Dumic","year":"2017","unstructured":"Dumic KK, Grubic Z, Yuen T, et al. Molecular genetic analysis in 93 patients and 193 family members with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Croatia. J Steroid Biochem Mol Biol. 2017;165(Pt A):51\u20136.","journal-title":"J Steroid Biochem Mol Biol."},{"issue":"34","key":"969_CR16","doi-asserted-by":"publisher","first-page":"20916","DOI":"10.1016\/S0021-9258(17)45304-X","volume":"265","author":"MT Tusie-Luna","year":"1990","unstructured":"Tusie-Luna MT, Traktman P, White PC. Determination of functional effects of mutations in the steroid 21-hydroxylase gene (CYP21) using recombinant vaccinia virus. J Biol Chem. 1990;265(34):20916\u201322.","journal-title":"J Biol Chem."},{"key":"969_CR17","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1159\/000342179","volume":"40","author":"D Pignatelli","year":"2013","unstructured":"Pignatelli D. Non-classic adrenal hyperplasia due to the deficiency of 21-hydroxylase and its relation to polycystic ovarian syndrome. Front Horm Res. 2013;40:158\u201370.","journal-title":"Front Horm Res."},{"issue":"1312","key":"969_CR18","first-page":"77","volume":"123","author":"H Falhammar","year":"2010","unstructured":"Falhammar H. Non-classic congenital adrenal hyperplasia due to 21-hydoxylase deficiency as a cause of infertility and miscarriages. N Z Med J. 2010;123(1312):77\u201380.","journal-title":"N Z Med J."},{"key":"969_CR19","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/978-1-60761-459-3_25","volume":"603","author":"RJ Singh","year":"2010","unstructured":"Singh RJ. Quantitation of 17-OH-progesterone (OHPG) for diagnosis of congenital adrenal hyperplasia (CAH). Methods Mol Biol. 2010;603:271\u20137.","journal-title":"Methods Mol Biol."},{"key":"969_CR20","doi-asserted-by":"publisher","unstructured":"Maffazioli GDN, Bachega TASS, Hayashida SAY, Gomes LG, Valassi HPL, Marcondes JAM, Mendonca BB, Baracat EC, Maciel GAR. Steroid Screening Tools Differentiating Nonclassical Congenital Adrenal Hyperplasia and Polycystic Ovary Syndrome. J Clin Endocrinol Metab.\u00a0United States;\u00a02020;105(8):e2895\u2013902.\u00a0ISSN: 0021-972X. https:\/\/doi.org\/10.1210\/clinem\/dgaa369.","DOI":"10.1210\/clinem\/dgaa369"},{"issue":"3","key":"969_CR21","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1055\/s-2003-43307","volume":"21","author":"C Moran","year":"2003","unstructured":"Moran C, Azziz R. 21-hydroxylase-deficient nonclassic adrenal hyperplasia: the great pretender. Semin Reprod Med. 2003;21(3):295\u2013300.","journal-title":"Semin Reprod Med."},{"issue":"3","key":"969_CR22","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1530\/EJE-17-0862","volume":"178","author":"M Engels","year":"2018","unstructured":"Engels M, Gehrmann K, Falhammar H, et al. Gonadal function in adult male patients with congenital adrenal hyperplasia. Eur J Endocrinol. 2018;178(3):285\u201394.","journal-title":"Eur J Endocrinol."},{"issue":"6","key":"969_CR23","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1097\/MED.0b013e32835a1a2e","volume":"19","author":"SF Witchel","year":"2012","unstructured":"Witchel SF. Management of CAH during pregnancy: optimizing outcomes. Curr Opin Endocrinol Diabetes Obes. 2012;19(6):489\u201396.","journal-title":"Curr Opin Endocrinol Diabetes Obes."},{"issue":"3","key":"969_CR24","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1210\/jc.2014-3809","volume":"100","author":"A Mallappa","year":"2015","unstructured":"Mallappa A, Sinaii N, Kumar P, et al. A phase 2 study of Chronocort, a modified-release formulation of hydrocortisone, in the treatment of adults with classic congenital adrenal hyperplasia. J Clin Endocrinol Metab. 2015;100(3):1137\u201345.","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"969_CR25","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1111\/cen.13429","volume":"87","author":"O Eyal","year":"2017","unstructured":"Eyal O, Ayalon-Dangur I, Segev-Becker A, Schachter-Davidov A, Israel S, Weintrob N. Pregnancy in women with nonclassic congenital adrenal hyperplasia: Time to conceive and outcome. Clin Endocrinol (Oxf). 2017;87(5):552\u20136.","journal-title":"Clin Endocrinol (Oxf)."},{"key":"969_CR26","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.psyneuen.2018.02.033","volume":"91","author":"L Karlsson","year":"2018","unstructured":"Karlsson L, Nordenstr\u00f6m A, Hirvikoski T, Lajic S. Prenatal dexamethasone treatment in the context of at risk CAH pregnancies: Long-term behavioral and cognitive outcome. Psychoneuroendocrinology. 2018;91:68\u201374.","journal-title":"Psychoneuroendocrinology."},{"issue":"5","key":"969_CR27","doi-asserted-by":"publisher","first-page":"233","DOI":"10.21037\/atm.2019.12.156","volume":"8","author":"J Guo","year":"2020","unstructured":"Guo J, Fang M, Zhuang S, et al. Prenatal dexamethasone exposure exerts sex-specific effect on placental oxygen and nutrient transport ascribed to the differential expression of IGF2. Ann Transl Med. 2020;8(5):233.","journal-title":"Ann Transl Med."},{"issue":"9","key":"969_CR28","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1515\/jpem-2018-0260","volume":"31","author":"J Sellick","year":"2018","unstructured":"Sellick J, Aldridge S, Thomas M, Cheetham T. Growth of patients with congenital adrenal hyperplasia due to 21-hydroxylase in infancy, glucocorticoid requirement and the role of mineralocorticoid therapy. J Pediatr Endocrinol Metab. 2018;31(9):1019\u201322.","journal-title":"J Pediatr Endocrinol Metab."}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-022-00969-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-022-00969-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-022-00969-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T14:25:57Z","timestamp":1674915957000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-022-00969-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,7]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["969"],"URL":"https:\/\/doi.org\/10.1186\/s12902-022-00969-w","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,7]]},"assertion":[{"value":"2 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The images or other personal or clinical details of participants are consented for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The written informed consent to publish this information was obtained from study participants. The copy of the consent form is available for review by the Editor of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"57"}}